Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Gulei

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Molecular Therapy. Nucleic Acids|July 20, 2019
Activation of Necroptosis by Engineered Self Tumor-Derived Exosomes Loaded with CRISPR/Cas9Diana Gulei, Ioana Berindan-Neagoe
Trends in Biotechnology|February 27, 2018
Restoring the p53 'Guardian' Phenotype in p53-Deficient Tumor Cells with CRISPR/Cas9Sergiu Chira, Diana Gulei, Amin Hajitou, et al.
International Journal of Molecular Sciences|August 23, 2020
The Malignant Role of Exosomes as Nanocarriers of Rare RNA SpeciesAlina-Andreea Zimta, Olafur Eysteinn Sigurjonsson, Diana Gulei, et al.
Pharmaceutics|August 10, 2021
Cancer Mechanisms and Emerging TherapiesDiana Gulei, Alice Indini, Carmen Jerónimo, et al.
Molecular Aspects of Medicine|September 28, 2019
The extensive role of miR-155 in malignant and non-malignant diseasesDiana Gulei, Lajos Raduly, Elisabetta Broseghini, et al.
Cancers|November 25, 2023
Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic PerspectiveRaluca Munteanu, Ciprian Tomuleasa, Cristina-Adela Iuga, et al.
Cellular and Molecular Life Sciences : CMLS|February 27, 2019
Comprehensive analysis of circular RNAs in pathological states: biogenesis, cellular regulation, and therapeutic relevanceCornelia Braicu, Andreea-Alina Zimta, Diana Gulei, et al.
Medicine and Pharmacy Reports|September 5, 2024
Impact of assessing the emotional health status in the management of cancer patientsLiliana Policiuc, Cecilia Bica, Diana Gulei, et al.
Molecular Aspects of Medicine|November 10, 2019
Altered expression of miR-181 affects cell fate and targets drug resistance-related mechanismsCornelia Braicu, Diana Gulei, Lajos Raduly, et al.
Biotechnology Advances|November 14, 2017
Targeting ncRNAs by plant secondary metabolites: The ncRNAs game in the balance towards malignancy inhibitionDiana Gulei, Nikolay Mehterov, Seyed Mohammad Nabavi, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Molecular Therapy. Nucleic Acids|July 20, 2019
Activation of Necroptosis by Engineered Self Tumor-Derived Exosomes Loaded with CRISPR/Cas9Diana Gulei, Ioana Berindan-Neagoe
Trends in Biotechnology|February 27, 2018
Restoring the p53 'Guardian' Phenotype in p53-Deficient Tumor Cells with CRISPR/Cas9Sergiu Chira, Diana Gulei, Amin Hajitou, et al.
International Journal of Molecular Sciences|August 23, 2020
The Malignant Role of Exosomes as Nanocarriers of Rare RNA SpeciesAlina-Andreea Zimta, Olafur Eysteinn Sigurjonsson, Diana Gulei, et al.
Pharmaceutics|August 10, 2021
Cancer Mechanisms and Emerging TherapiesDiana Gulei, Alice Indini, Carmen Jerónimo, et al.
Molecular Aspects of Medicine|September 28, 2019
The extensive role of miR-155 in malignant and non-malignant diseasesDiana Gulei, Lajos Raduly, Elisabetta Broseghini, et al.
Cancers|November 25, 2023
Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic PerspectiveRaluca Munteanu, Ciprian Tomuleasa, Cristina-Adela Iuga, et al.
Cellular and Molecular Life Sciences : CMLS|February 27, 2019
Comprehensive analysis of circular RNAs in pathological states: biogenesis, cellular regulation, and therapeutic relevanceCornelia Braicu, Andreea-Alina Zimta, Diana Gulei, et al.
Medicine and Pharmacy Reports|September 5, 2024
Impact of assessing the emotional health status in the management of cancer patientsLiliana Policiuc, Cecilia Bica, Diana Gulei, et al.
Molecular Aspects of Medicine|November 10, 2019
Altered expression of miR-181 affects cell fate and targets drug resistance-related mechanismsCornelia Braicu, Diana Gulei, Lajos Raduly, et al.
Biotechnology Advances|November 14, 2017
Targeting ncRNAs by plant secondary metabolites: The ncRNAs game in the balance towards malignancy inhibitionDiana Gulei, Nikolay Mehterov, Seyed Mohammad Nabavi, et al.
Pageof 9